BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2473582)

  • 1. [Maternal serum AFP screening in type I diabetic patients].
    Briese V
    Zentralbl Gynakol; 1989; 111(10):664-8. PubMed ID: 2473582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical screening for chromosomal disorders and neural tube defects (NTD): is adjustment of maternal alpha-fetoprotein (AFP) still appropriate in insulin-dependent diabetes mellitus (IDDM)?
    Sancken U; Bartels I
    Prenat Diagn; 2001 May; 21(5):383-6. PubMed ID: 11360279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased alpha-fetoprotein in amniotic fluid and maternal serum in diabetic pregnancy.
    Henriques CU; Damm P; Tabor A; Pedersen JF; Mølsted-Pedersen L
    Obstet Gynecol; 1993 Dec; 82(6):960-4. PubMed ID: 7694215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prenatal detection of open neural tube defects in a mass screening program by determination of alpha-fetoprotein concentration in maternal serum].
    Zwahr C; Körner H; Tinschert S; Horn A; Schulze M; Voigt M
    Zentralbl Gynakol; 1988; 110(3):158-67. PubMed ID: 2452529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prenatal diagnosis of neural tube defects. VIII. The importance of serum alpha-fetoprotein screening in diabetic pregnant women.
    Milunsky A; Alpert E; Kitzmiller JL; Younger MD; Neff RK
    Am J Obstet Gynecol; 1982 Apr; 142(8):1030-2. PubMed ID: 6176126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin-dependent diabetes mellitus and prenatal screening results: current experience from a regional screening programme.
    Crossley JA; Berry E; Aitken DA; Connor JM
    Prenat Diagn; 1996 Nov; 16(11):1039-42. PubMed ID: 8953638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prenatal diagnosis of neural tube defects. IV. Maternal serum alpha-fetoprotein screening.
    Milunsky A; Alpert E; Neff RK; Frigoletto FD
    Obstet Gynecol; 1980 Jan; 55(1):60-6. PubMed ID: 6153240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Increased AFP in maternal serum as an indication for invasive diagnosis].
    Gremm B; Sohn C; Beldermann F; Bastert G
    Zentralbl Gynakol; 1997; 119(11):560-6. PubMed ID: 9480612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of adjustment of maternal serum alpha-fetoprotein levels in insulin-dependent diabetes mellitus.
    Kramer RL; Yaron Y; O'Brien JE; Critchfield G; Ayoub M; Johnson MP; Qualls CR; Evans MI
    Am J Med Genet; 1998 Jan; 75(2):176-8. PubMed ID: 9450880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maternal serum screening for birth defects: results of a Connecticut regional program.
    Benn PA; Horne D; Craffey A; Collins R; Ramsdell L; Greenstein R
    Conn Med; 1996 Jun; 60(6):323-7. PubMed ID: 8706425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First-trimester screening for neural tube defects using alpha-fetoprotein.
    Bredaki FE; Poon LC; Birdir C; Escalante D; Nicolaides KH
    Fetal Diagn Ther; 2012; 31(2):109-14. PubMed ID: 22377693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Determination of maternal serum alpha fetoprotein with a Polish AFP radioimmunoassay--a suitable screening method for neural tube defects?].
    Schlosser H; Greiff R
    Zentralbl Gynakol; 1986; 108(15):914-8. PubMed ID: 2429479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum alpha-fetoprotein: II. Clinical evaluation of two automated immunoassays for maternal serum screening.
    Cate JC; Gadsden RH
    Ann Clin Lab Sci; 1991; 21(4):254-7. PubMed ID: 1713436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fetal malformation and serum alpha-fetoprotein concentration of diabetic mothers.
    Szabó M; Tóth T; Tóth Z; Szeifert GT; Csécsei K; Veress L; Papp Z
    Zentralbl Gynakol; 1986; 108(20):1228-36. PubMed ID: 2433853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Disorders of fetoplacental function in pregnant women with diabetes].
    Mikulíková L; Struplová J; Fialová L; Malbohan I
    Sb Lek; 1993; 94(2):173-7. PubMed ID: 7527583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Data from an alpha-fetoprotein pilot screening program in Maine.
    Haddow JE; Kloza EM; Smith DE; Knight GJ
    Obstet Gynecol; 1983 Nov; 62(5):556-60. PubMed ID: 6194484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of fetal outcome by urinary estriol, maternal serum placental lactogen, and alpha-fetoprotein in diabetes and hepatosis of pregnancy.
    Garoff L
    Obstet Gynecol; 1976 Dec; 48(6):659-66. PubMed ID: 63107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prenatal screening using maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol: two-year experience in a health maintenance organization.
    McDuffie RS; Haverkamp AD; Stark CF; Haverkamp C; Barth CK
    J Matern Fetal Med; 1996; 5(2):70-3. PubMed ID: 8796771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prenatal serum alpha-fetoprotein screening for neural tube defects.
    Macri JN; Weiss RR
    Obstet Gynecol; 1982 May; 59(5):633-9. PubMed ID: 6175932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Very low alpha-fetoprotein in Down syndrome maternal serum screening.
    Muller F; Dreux S; Sault C; Galland A; Puissant H; Couplet G; Lemay C; Larcher ME; Renom G;
    Prenat Diagn; 2003 Jul; 23(7):584-7. PubMed ID: 12868089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.